{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:29:49Z","timestamp":1760027389111},"reference-count":53,"publisher":"Informa Healthcare","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Expert Opinion on Investigational Drugs"],"published-print":{"date-parts":[[1999,5]]},"DOI":"10.1517\/13543784.8.5.555","type":"journal-article","created":{"date-parts":[[2005,5,4]],"date-time":"2005-05-04T18:34:17Z","timestamp":1115231657000},"page":"555-566","source":"Crossref","is-referenced-by-count":4,"title":["The therapeutic use of glycoprotein IIb\/IIIa inhibitors in acute coronary syndromes"],"prefix":"10.1517","volume":"8","author":[{"given":"Ganesh","family":"Manoharan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzanne J","family":"Maynard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"AA Jennifer","family":"Adgey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3197","published-online":{"date-parts":[[2005,2,23]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.53.4.363"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.92.3.657"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.89.4.1545"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1172\/JCI110973"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199506083322306"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)11086-3"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(87)90233-9"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.92.9.2373"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.eurheartj.a014698"},{"key":"CIT0012","doi-asserted-by":"crossref","first-page":"9907","DOI":"10.1182\/blood.V88.3.795.795","volume":"88","author":"WAGNER CL","year":"1996","journal-title":"Blood"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1016\/0268-960X(91)90031-7"},{"key":"CIT0015","doi-asserted-by":"crossref","first-page":"9935","DOI":"10.1016\/S0021-9258(18)61053-1","volume":"262","author":"CHARO IF","year":"1987","journal-title":"J. Biol. Chem."},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1016\/0955-0674(93)90036-P"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1016\/S0741-5214(94)70127-X"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)10452-9"},{"key":"CIT0020","first-page":"596","volume":"89","author":"SIMOONS ML","year":"1994","journal-title":"Randomized trial of a GP Ilb\/IIIa platelet receptor blocker in refractory unstable angina. Circulation"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.98.14.1358"},{"key":"CIT0022","first-page":"976","volume":"69","author":"GOULD RJ CHANG CTC","year":"1993","journal-title":"Throm. HaemosL"},{"key":"CIT0023","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.88.4.1512"},{"key":"CIT0024","first-page":"1498","volume":"338","author":"THE PLATELET RECEPTOR INHIBITION IN ISCHAEMIC SYNDROME MANAGEMENT","year":"1998","journal-title":"A comparison of aspirin plus tirofiban with as-pirin plus heparin for unstable angina. New Eng. J. Med."},{"key":"CIT0026","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199805213382102"},{"key":"CIT0028","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199805213382110"},{"key":"CIT0029","doi-asserted-by":"publisher","DOI":"10.1021\/jm00101a017"},{"key":"CIT0030","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1182\/blood.V80.10.2539.2539","volume":"80","author":"KOUNS WC","year":"1992","journal-title":"Blood"},{"key":"CIT0031","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.94.5.899"},{"key":"CIT0033","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.97.24.2386"},{"key":"CIT0035","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.96.5.1488"},{"key":"CIT0036","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(99)80345-2"},{"key":"CIT0037","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.91.8.2151"},{"key":"CIT0038","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)10172-0"},{"key":"CIT0039","first-page":"2083","volume":"94","author":"SCHULMAN SP","year":"1996","journal-title":"TOPOL EJet al.: Effects of Integrelin, a platelet glycoprotein Ilb\/Ifia receptor antagonist, in unstable angina: a ran-domized multicenter trial. Circulation"},{"key":"CIT0040","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199808133390704"},{"key":"CIT0042","doi-asserted-by":"publisher","DOI":"10.1021\/jm9509298"},{"key":"CIT0043","first-page":"340","volume":"97","author":"CANNON CP","year":"1998","journal-title":"Results of the TIMI 12 Trial. Circulation"},{"key":"CIT0045","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.76.1.142"},{"key":"CIT0046","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.94.5.911"},{"key":"CIT0047","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199404073301402"},{"key":"CIT0048","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(94)90007-8"},{"key":"CIT0049","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/16.suppl_L.43"},{"key":"CIT0050","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(97)00110-1"},{"key":"CIT0051","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1997.03550060055036"},{"key":"CIT0052","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199706123362401"},{"key":"CIT0053","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)06113-3"},{"key":"CIT0054","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.96.5.1445"},{"key":"CIT0055","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)10172-0"},{"key":"CIT0056","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.98.13.1268"},{"key":"CIT0057","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.91.12.2882"},{"key":"CIT0058","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.97.2.211"},{"key":"CIT0059","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)70523-7"},{"key":"CIT0061","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(98)00474-4"},{"key":"CIT0064","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.94.4.629"},{"key":"CIT0065","first-page":"846","volume":"95","author":"IMPACT-AMI INVESTIGATORS","year":"1997","journal-title":"Results of a randomized, placebo-controlled, dose-ranging trial. Circulation"},{"key":"CIT0066","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(93)90041-X"}],"container-title":["Expert Opinion on Investigational Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1517\/13543784.8.5.555","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,10]],"date-time":"2021-07-10T15:08:56Z","timestamp":1625929736000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/full\/10.1517\/13543784.8.5.555"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,5]]},"references-count":53,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2005,2,23]]},"published-print":{"date-parts":[[1999,5]]}},"alternative-id":["10.1517\/13543784.8.5.555"],"URL":"https:\/\/doi.org\/10.1517\/13543784.8.5.555","relation":{},"ISSN":["1354-3784","1744-7658"],"issn-type":[{"value":"1354-3784","type":"print"},{"value":"1744-7658","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,5]]}}}